S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pernix Therapeutics Reports Third Quarter 2014 Financial Results and Reaffirms Guidance|
|CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million (2015/1/20)|
|Pernix Therapeutics to Report Q3 2014 Financial Results|
|Pernix Therapeutics Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference|
|Pernix Submits sNDA for TREXIMET® Use in Adolescent Patients|
|Pernix Therapeutics Inc. to Present at the Oppenheimer Healthcare Conference in New York, NY|
|Pernix Therapeutics Announces FDA Acceptance With Priority Review of Its TREXIMET® sNDA for Use in Adolescent Patients|
|UPDATE: Strong bull trend reaches latest technical test (2014/11/18)|
|Strong bull trend reaches latest technical test (2014/11/18)|
|UPDATE: Strong bull trend reaches uncharted territory (2014/11/25)|
Click above to view more mutual fund data and stats for gtap - Pernix Therapeutics Holdings Inc.